Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina

American Heart Journal

Volumn 152, Issue 4, 2006, Pages 785-792

  Bertoni, Alain G ^a   Bonds, Denise E ^a   Steffes, Susan ^b   Jackson, Eric ^b   Crago, Lenore ^a   Balasubramanyam, Aarthi ^a   Chen, Haiying ^a   Goff Jr , David C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Carolinas Center for Medical Excellence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL PRACTICE; DECISION MAKING; DEMOGRAPHY; DYSLIPIDEMIA; FEMALE; HEALTH EDUCATION; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SCREENING; TIME SERIES ANALYSIS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; CHOLESTEROL; GUIDELINE ADHERENCE; HUMANS; HYPERLIPIDEMIAS; MASS SCREENING; MIDDLE AGED; NORTH CAROLINA; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; PROFESSIONAL PRACTICE;

EID: 33748702066     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.04.017     Document Type: Article

References (31)

1. LaRosa J.C., He J., and Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282 (1999) 2340-2346
2. Pearson T.A., Laurora I., Chu H., et al. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
3. Stafford R.S., Blumenthal D., and Pasternak R.C. Variations in cholesterol management practices of U.S. physicians. J Am Coll Cardiol 29 (1997) 139-146
4. Cohen M.V., Byrne M.J., Levine B., et al. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease. Circulation 83 (1991) 1294-1304
5. Giles W.H., Anda R.F., Jones D.H., et al. Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA 269 (1993) 1133-1138
6. Nieto F.J., Alonso J., Chambless L.E., et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med 155 (1995) 677-684
7. Hoerger T.J., Bala M.V., Bray J.W., et al. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am J Cardiol 82 (1998) 61-65
8. Smith Jr. S.C. Clinical treatment of dyslipidemia: practice patterns and missed opportunities. Am J Cardiol 86 (2000) 62L-65L
9. Straka R.J., Taheri R., Cooper S.L., et al. Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy 21 (2001) 818-827
10. Goff Jr. D.C., Bertoni A.G., Kramer H., et al. Dyslipidemia prevalence, treatment and control in the MESA Study: gender, ethnicity and coronary artery calcium. Circulation 113 (2006) 647-656
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
12. Aliyu Z.Y., Yousif S.B., Plantholt K., et al. Assessing compliance of cardiologists with the National Cholesterol Education Program (NCEP) III guidelines in an ambulatory care setting. Lipids Health Dis 3 (2004) 9
13. Olson K.L., Rasmussen J., Sandhoff B.G., et al. Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Arch Intern Med 165 (2005) 49-54
14. Ma J., Sehgal N.L., Ayanian J.Z., et al. National trends in statin use by coronary heart disease risk category. PLoS Med 2 (2005) e123
15. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
16. O'Neill L., and Kuder J. Explaining variation in physician practice patterns and their propensities to recommend services. Med Care Res Rev 62 (2005) 339-357
17. Weiner J.P., Starfield B.H., Powe N.R., et al. Ambulatory care practice variation within a Medicaid program. Health Serv Res 30 (1996) 751-770
18. Zocchetti C., Consonni D., and Bertazzi P.A. Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int J Epidemiol 26 (1997) 220-223 [JID-7802871]
19. Sueta C.A., Chowdhury M., Boccuzzi S.J., et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol 83 (1999) 1303-1307
20. McBride P., Schrott H.G., Plane M.B., et al. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med 158 (1998) 1238-1244
21. Bramlet D.A., King H., Young L., et al. Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists. Am J Cardiol 80 (1997) 39H-44H
22. Abookire S.A., Karson A.S., Fiskio J., et al. Use and monitoring of "statin" lipid-lowering drugs compared with guidelines. Arch Intern Med 161 (2001) 53-58
23. Straka R.J., Taheri R., Cooper S.L., et al. Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy 21 (2001) 818-827
24. Hoerger T.J., Bala M.V., Bray J.W., et al. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am J Cardiol 82 (1998) 61-65
25. Quilliam B.J., Perez H.E., Andros V., et al. Quantifying the effect of applying the NCEP ATP III criteria in a managed care population treated with statin therapy. J Manag Care Pharm 10 (2004) 244-250
26. Patel L., Abriam-Yago K., and Harkins E.A. A comparison study of the utilization of National Cholesterol Education Program guidelines by cardiology and internal medicine practices: implications for the advanced practice nurse. J Am Acad Nurse Pract 15 (2003) 557-562
27. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
28. Hyman D.J., and Pavlik V.N. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 160 (2000) 2281-2286
29. Hobbs F.D., and Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 19 (2002) 596-604
30. Yarzebski J., Bujor C.F., Goldberg R.J., et al. A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction. Arch Intern Med 162 (2002) 797-804
31. Benner J.S., Tierce J.C., Ballantyne C.M., et al. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics 22 Suppl 3 (2004) 13-23